A Universal Threshold? High-Sensitivity Troponin I Emerges as a Robust Prognostic Tool in Wild-Type Transthyretin Amyloid Cardiomyopathy
Highlights
High-sensitivity cardiac troponin I (hs-cTnI) is an independent and potent predictor of all-cause mortality in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM).
A standardized threshold of 80 ng/L for hs-cTnI has been identified across three major diagnostic assays (Abbott, Beckman Coulter, and Siemens), simplifying clinical application.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.